Compound Library Screening Services

Compound Library Screening Services

Overview Library Types Screening Strategy Applications

Overview

Compound library screening is a high-throughput in vivo technique that uses zebrafish embryos or larvae to screen large collections of chemical compounds for the quick identification of physiologically active candidates. This technique, combining automated chemical delivery, standardized phenotypic scoring, and quantitative data analysis, allows for the efficient screening of hundreds to thousands of compounds under physiologically relevant conditions.

Our Zebrafish Compound Library Screening Services support a wide range of discovery programs, from hit identification and lead discovery to drug repurposing and chemical biology research. Screening using zebrafish not only supports the discovery of compounds with desired biological activity, but also allows for the concurrent assessment of efficacy-related phenotypes, developmental effects, and early toxicity, thereby providing valuable in vivo evidence for compound prioritization at an early stage of drug discovery.

When to Use Compound Library Screening

Compound library screening is particularly suited to projects that require rapid in vivo evaluation of vast or diverse compound libraries. Common applications include:

  • Hit Discovery: Screen proprietary or commercial libraries for compounds with desired biological activity.
  • Drug Repurposing: Evaluate compounds already approved by the FDA or characterized in the clinic for new therapeutic applications.
  • Natural Product Screening: Screening of natural products, microbial metabolites or botanical extracts for novel biological activity.
  • Comparative Compound Evaluation: Compare analogs, structural series, or lead optimization candidates to identify the most promising compounds.
  • In Vivo Prioritization: Validate and prioritize candidates identified from cell-based assays before advancing to studies.

Library Types We Support

We support a wide variety of compound collections and tailor screening strategies according to library composition and project goals.

FDA‑Approved Drug Libraries

Support drug repurposing by evaluating approved therapeutics in new disease models. Their well‑established pharmacological and safety profiles facilitate rapid candidate prioritization.

Bioactive Compound Libraries

Contain compounds with known biological activities or molecular targets, making them well suited for mechanism studies and the discovery of novel in vivo biological activities.

Natural Product Libraries

Include plant‑derived compounds, microbial metabolites, and marine natural products. These libraries are valuable for discovering novel bioactive molecules while simultaneously assessing early toxicity.

Focused Libraries

Designed around specific target families, signaling pathways, disease areas, or structural scaffolds, these libraries are ideal for targeted screening and lead optimization.

Chemical Probe Libraries

Contain selective chemical probes and pathway modulators for mechanism studies, target validation, and pathway interrogation in zebrafish models.

Customer‑Supplied Libraries

We support customized screening of customer‑supplied libraries with flexible assay designs, including compound concentration, solvent conditions, dosing strategy, exposure duration, and screening endpoints.

Screening Strategy Design

Every screening campaign is designed according to the scientific objectives, compound library characteristics, and biological questions of each project. Our team works closely with clients to establish an efficient and reliable screening strategy.

A

Primary Screening

Large-scale primary screening is performed to rapidly identify compounds that produce measurable biological responses or desired phenotypic changes under standardized assay conditions.

B

Dose-Range Screening

Multiple concentration levels can be evaluated to assess concentration-dependent responses, estimate the effective activity window, and support subsequent dose-response studies.

C

Comparative Screening

Parallel comparison of compound series, structural analogs, reformulated candidates, or different production batches helps prioritize molecules with superior in vivo activity and consistency.

D

Phenotype Rescue Screening

Disease models or chemically induced injury models can be used to identify compounds capable of reversing pathological phenotypes or restoring normal biological function.

E

Toxicity Counter-Screening

Secondary toxicity evaluation helps distinguish genuine pharmacological activity from nonspecific effects caused by developmental abnormalities, behavioral suppression, or systemic toxicity, thereby reducing false-positive hits.

F

Secondary Confirmation

Promising candidates identified during primary screening are re-tested under independent experimental conditions to confirm reproducibility, strengthen confidence in hit selection, and support downstream validation studies.

Compound Handling and Assay Preparation

Reliable compound preparation is essential for reproducible screening results. Our assay setup can include:

  • Compound registration and plate formatting
  • Solubility and DMSO compatibility assessment
  • Single-dose or multi-dose assay design
  • Positive and negative control selection
  • Biological and technical replicate design
  • Plate map optimization
  • Randomization strategies when required

Data Analysis and Hit Identification

Screening data are processed using standardized quality control and statistical analysis to identify high-confidence hits and prioritize candidates for downstream studies.

Our analysis may include:

  • Assay quality control
  • Response normalization and Z-score analysis
  • Hit threshold definition
  • Hit ranking and prioritization
  • Dose-response confirmation
  • Toxicity filtering
  • Candidate selection
  • Preliminary structure–activity relationship (SAR) trend analysis

Applications

Our compound library screening platform supports a broad range of discovery programs, including:

  • Drug repurposing
  • Hit discovery
  • Lead identification
  • Natural product evaluation
  • Chemical biology research
  • In vivo prioritization following in vitro screening
  • Early efficacy and toxicity triage
  • Candidate selection for secondary validation

For research use only. Not intended for any clinical use.

Quick Inquiry

Tell Us What Happened

Please contact us if you have questions about our company, our products, or general enquiries.

Please use the form.